390 related articles for article (PubMed ID: 26036864)
1. Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes.
Nakase I; Kobayashi NB; Takatani-Nakase T; Yoshida T
Sci Rep; 2015 Jun; 5():10300. PubMed ID: 26036864
[TBL] [Abstract][Full Text] [Related]
2. Vectorization of biomacromolecules into cells using extracellular vesicles with enhanced internalization induced by macropinocytosis.
Nakase I; Noguchi K; Fujii I; Futaki S
Sci Rep; 2016 Oct; 6():34937. PubMed ID: 27748399
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
4. A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.
Du Y; Shang BY; Sheng WJ; Zhang SH; Li Y; Miao QF; Zhen YS
Oncotarget; 2016 Sep; 7(36):58418-58434. PubMed ID: 27517152
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes.
Nakase I; Futaki S
Sci Rep; 2015 May; 5():10112. PubMed ID: 26011176
[TBL] [Abstract][Full Text] [Related]
6. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
7. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Kamerkar S; LeBleu VS; Sugimoto H; Yang S; Ruivo CF; Melo SA; Lee JJ; Kalluri R
Nature; 2017 Jun; 546(7659):498-503. PubMed ID: 28607485
[TBL] [Abstract][Full Text] [Related]
8. Endocytosis separates EGF receptors from endogenous fluorescently labeled HRas and diminishes receptor signaling to MAP kinases in endosomes.
Pinilla-Macua I; Watkins SC; Sorkin A
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2122-7. PubMed ID: 26858456
[TBL] [Abstract][Full Text] [Related]
9. Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery.
Nakase I; Noguchi K; Aoki A; Takatani-Nakase T; Fujii I; Futaki S
Sci Rep; 2017 May; 7(1):1991. PubMed ID: 28512335
[TBL] [Abstract][Full Text] [Related]
10. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
11. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery.
Tian T; Zhu YL; Zhou YY; Liang GF; Wang YY; Hu FH; Xiao ZD
J Biol Chem; 2014 Aug; 289(32):22258-67. PubMed ID: 24951588
[TBL] [Abstract][Full Text] [Related]
12. Association of p120 ras GAP with endocytic components and colocalization with epidermal growth factor (EGF) receptor in response to EGF stimulation.
Wang Z; Tung PS; Moran MF
Cell Growth Differ; 1996 Jan; 7(1):123-33. PubMed ID: 8788041
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Microvesicles Modified with Arginine-Rich Peptides for Active Macropinocytosis Induction and Delivery of Therapeutic Molecules.
Morimoto K; Ishitobi J; Noguchi K; Kira R; Kitayama Y; Goto Y; Fujiwara D; Michigami M; Harada A; Takatani-Nakase T; Fujii I; Futaki S; Kanada M; Nakase I
ACS Appl Mater Interfaces; 2024 Apr; 16(14):17069-17079. PubMed ID: 38563247
[TBL] [Abstract][Full Text] [Related]
14. High-content, full genome siRNA screen for regulators of oncogenic HRAS-driven macropinocytosis.
Fennell M; Commisso C; Ramirez C; Garippa R; Bar-Sagi D
Assay Drug Dev Technol; 2015 Sep; 13(7):347-55. PubMed ID: 26267765
[TBL] [Abstract][Full Text] [Related]
15. Ras and exosome signaling.
Sexton RE; Mpilla G; Kim S; Philip PA; Azmi AS
Semin Cancer Biol; 2019 Feb; 54():131-137. PubMed ID: 30769101
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor regulates protein kinase A activity in murine fibrosarcoma cells: differences between metastatic and nonmetastatic tumor cell variants.
Fishman D; Galitzki L; Priel E; Segal S
Cancer Res; 1997 Dec; 57(23):5410-5. PubMed ID: 9393768
[TBL] [Abstract][Full Text] [Related]
17. Piezo1 activation using Yoda1 inhibits macropinocytosis in A431 human epidermoid carcinoma cells.
Kuriyama M; Hirose H; Masuda T; Shudou M; Arafiles JVV; Imanishi M; Maekawa M; Hara Y; Futaki S
Sci Rep; 2022 Apr; 12(1):6322. PubMed ID: 35428847
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
[TBL] [Abstract][Full Text] [Related]
19. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.
Al Soraj M; He L; Peynshaert K; Cousaert J; Vercauteren D; Braeckmans K; De Smedt SC; Jones AT
J Control Release; 2012 Jul; 161(1):132-41. PubMed ID: 22465675
[TBL] [Abstract][Full Text] [Related]
20. Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis.
Ramirez C; Hauser AD; Vucic EA; Bar-Sagi D
Nature; 2019 Dec; 576(7787):477-481. PubMed ID: 31827278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
